Vol. 40 | Vol. 40(6) - November / December 2022 | COLUMN: API of the Month

Tapinarof

by 6 December 2022

R. Souza 6 December 2022

Tapinarof

RODRIGO SOUZA
Biocatalysis and Organic Synthesis Group, Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazils

ABOUT THE AUTHOR

Rodrigo Souza – Since I started my independent career, I have pursuit the development of new technologies to guide research by innovative ideas. We have been working at Federal University of Rio de Janeiro on the establishment of continuous flow technology for active pharmaceutical ingredients (API) synthesis in Brazil, showing that is possible to reduce costs on production allowing the reduction of the final price of the medicine.

Survey finds high levels of early adoption of EMA’s centralized clinical trials information system

Latest issue

Vol. 44(4) – July / August 2026

View Issue

Content from magazine

“Contents from Magazine” offers curated articles and insights from the field of chemistry, focused on research, data, and scientific developments

View all content

Tapinarof

You may also like

Therapeutic oligonucleotides: the promises are up for delivery

A new guideline harmonises product carbon footprint calculations for c...

How to develop a CO2-neutral bioprocess

Oligonucleotide therapeutics. A long and windy road towards future med...

Building skills to power a data-first regulatory ecosystem

Building transparency into pharmaceutical supply chains with discovera...

Applications of polymeric resins in medical devices for life saving tr...

Titanium Dioxide: updates